Document is current
Any future updates will be listed below
-
Authors
Zhou, Lu
Liang, Hongsheng
Nie, Chenyi
Zhou, Jiaxin
Li, Kuo
Zhang, Xi
Xu, Jiahang
Hu, Renjie
Gao, Aili
-
Funding
Funding for this research was provided by:
the National Natural Science Foundations of China ((No.82071368, 82271340))
the Outstanding Youth Funding of Harbin Medical University ((No.HYD2020JQ0016).)
- License Information
-
More Information
Article History
Accepted: 23 July 2025
First Online: 20 August 2025
Declarations
:
: All animal experiments of this research were completed in Harbin hvriwk Biological Technology Development. All procedures performed in studies involving animals were in accordance with the ethical standards of the institutional and/or national research committee (Harbin Vic Biological Technology Development Co., Ltd., Harbin, China and Northeast Agricultural University, Harbin, P. R. China). The protocol was approved by the management and welfare of experimental animal ethics committee, Animal Experiment of Harbin hvriwk Biological Technology Development Co., Ltd., Harbin, China and Northeast Agricultural University, Harbin, P. R. China (230,707–04-GR).The collection of human glioma specimens involved in the experiment and the study protocol were submitted to the Ethics Committee of the First Affiliated Hospital of Harbin Medical University for review and approval(IRB-AF/SC-04/02.0).
: Written informed consent has been obtained from the patients to publish this paper.
: All authors read and agreed to publish the article.
: The authors disclose no potential conflicts of interest.
